News

The Max Delbrück Center hosted a graduation ceremony to honor 20 young researchers who have successfully defended their PhD theses this year. They were awarded their diplomas in front of proud colleagues, friends and family.

Simon Haas receives a Proof-of-Concept Grant from the European Research Council in the amount of €150,000. Immunotherapies use the immune system to fight against cancer. Haas' team from the joint single-cell focus of Max Delbrück Center, BIH, and Charité is developing methods to predict the efficacy of immunotherapies.

Are there measurable biological changes that occur over time that can predict the development of chronic disease? The German National Cohort Study aims to find out. The study has just started its third round of testing. All participants are encouraged to return for their re-examinations.

Researchers in Gary Lewin’s lab at the Max Delbrück Center have identified an ion channel that contributes to chronic pain, suggesting a new target for pain medication. The study was published in “Brain.”

At the Max Delbrück Center summer party, employees Daniela Dixon, Matthias Runow and Ingrid Ziegenhagen won this year’s Silent Hero Award. The award recognizes the commitment of employees whose hard work behind the scenes keeps our research running smoothly.

The Max Delbrück Center, Berlin, celebrates its new, innovative research building with a “topping-out ceremony.” The Imaging Innovation Center, designed by the architectural firm heinlewischer, will host researchers specializing in imaging and analysis alongside data experts under one roof starting in 2026.

Christian Panetzky is the sustainability coordinator at the Max Delbrück Center. He helps to make laboratories eco-friendly and discusses the integration of sustainability with cutting-edge research. The book he recommends inspires confidence in times of crisis.

Professor Holger Gerhardt from the DZHK partner site Berlin was newly elected to the Board of Directors by the General Assembly: He will take office on 1 July 2024.

On July 8, the Max Delbrück Center and Bruker will kick off a strategic partnership to build a first-of-its-kind innovation hub for systems medicine. The new center will focus on the development and application of mass spectrometry based single-cell and multi-omics technologies.

Through various initiatives, the Max Delbrück Center contributes to an objective debate on animal testing. For the second time, the “Understanding Animal Research” initiative has awarded the center the seal of approval for exemplary communication in experimental animal research.